Majority (50%) of the drug candidates are being evaluated in phase I clinical studies to ease the complexities associated with PSP.

Progressive supranuclear palsy (PSP) is a very rare yet complex condition that affects the working of the brain. Progressive shows that its symptoms will keep on worsening with time, supranuclear means the region of the brain that is affected known as nuc...